Philadelphia, United States
GlaxoSmithKline's venture arm invests worldwide in promising life science enterprises that are dedicated to pioneering research that will have a significant effect on healthcare.
127
Total Investments
70
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Finance, Financial Services +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About SR One
Recent Investments (127)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Private Placement Vc | •••••• | Jun 2026 | |
| Series A | •••••• | Mar 2026 | |
| Series B | •••••• | Sep 2025 | |
| Series B | •••••• | Sep 2025 | |
| Series A | •••••• | Nov 2024 | |
•••• ••••
|
Series B | •••••• | Sep 2024 |
|
•••• ••••
|
Series C | •••••• | Jul 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Series D | •••••• | Mar 2024 |
|
•••• ••••
|
Post Ipo Equity | •••••• | Feb 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
